Thomas E. Merchant

31.8k total citations · 3 hit papers
444 papers, 17.9k citations indexed

About

Thomas E. Merchant is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Thomas E. Merchant has authored 444 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Genetics, 179 papers in Pulmonary and Respiratory Medicine and 94 papers in Neurology. Recurrent topics in Thomas E. Merchant's work include Glioma Diagnosis and Treatment (245 papers), Neuroblastoma Research and Treatments (74 papers) and Childhood Cancer Survivors' Quality of Life (66 papers). Thomas E. Merchant is often cited by papers focused on Glioma Diagnosis and Treatment (245 papers), Neuroblastoma Research and Treatments (74 papers) and Childhood Cancer Survivors' Quality of Life (66 papers). Thomas E. Merchant collaborates with scholars based in United States, Netherlands and United Kingdom. Thomas E. Merchant's co-authors include Larry E. Kun, Amar Gajjar, Xiaoping Xiong, Raymond K. Mulhern, Shengjie Wu, Heather M. Conklin, Wilburn E. Reddick, Chenghong Li, Robert A. Sanford and Frederick A. Boop and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Thomas E. Merchant

433 papers receiving 17.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Late neurocognitive sequelae in survivors of brain tumours in childhood

2004 648 citations Thomas E. Merchant, Amar Gajjar et al. profile →
Radiation Dose–Volume Effects in the Brain

2010 523 citations Thomas E. Merchant et al. International Journal of Radiation Oncology*Biology*Physics profile →
Craniopharyngioma

2019 304 citations Thomas E. Merchant et al. profile →

Peers

Countries citing papers authored by Thomas E. Merchant

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Merchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Merchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Merchant more than expected).

Fields of papers citing papers by Thomas E. Merchant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Merchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Merchant. The network helps show where Thomas E. Merchant may publish in the future.

Co-authorship network of co-authors of Thomas E. Merchant

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Merchant. A scholar is included among the top collaborators of Thomas E. Merchant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Merchant. Thomas E. Merchant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Internalizing Symptoms and Their Impact on Patient-Reported Health-Related Quality of Life and Fatigue among Patients with Craniopharyngioma During Proton Radiation Therapy 2024 ·Children ·Belinda N. Mandrell, (unknown), Yimei Li, (unknown), (unknown), Jason M. Ashford, Thomas E. Merchant, Heather M. Conklin, (unknown)	4
2	CT- and MR-based image-based data mining are consistent in the brain 2024 ·Physica Medica ·(unknown), A. Davey, Eliana Vásquez Osorio, Austin M. Faught, Andrew Green, (unknown), (unknown), (unknown), Martin G. McCabe, Thomas E. Merchant, Marcel van Herk, Marianne Aznar	0
3	Evaluating the Impact of Bowel Gas Variations for Wilms’ Tumor in Pediatric Proton Therapy 2024 ·Cancers ·(unknown), (unknown), Jinsoo Uh, Chia‐Ho Hua, Thomas E. Merchant, (unknown), Andrew M. Davidoff, Dylan E. Graetz, Matthew J. Krasin	1
4	Social cognition and adjustment in adult survivors of pediatric central nervous system tumors 2023 ·Cancer ·(unknown), Victoria W. Willard, Amar Gajjar, Thomas E. Merchant, Deo Kumar Srivastava, Gregory T. Armstrong, Melissa M. Hudson, Kevin R. Krull, Tara M. Brinkman	4
5	The feasibility and acceptability of mobile ecological momentary assessment to evaluate sleep, family functioning, and affect in patients with pediatric craniopharyngioma 2023 ·Journal of Psychosocial Oncology ·(unknown), Marcia A. Winter, (unknown), Thomas E. Merchant, Valerie McLaughlin Crabtree	1
6	Tackling Pediatric Low-Grade Gliomas: A Global Perspective 2023 ·JCO Global Oncology ·Daniel C. Moreira, Catherine G. Lam, Nickhill Bhakta, Frederick A. Boop, Jason Chiang, Thomas E. Merchant, Carlos Rodríguez‐Galindo, Amar Gajjar, Ibrahim Qaddoumi	7
7	Prediabetes and Associated Risk of Cardiovascular Events and Chronic Kidney Disease Among Adult Survivors of Childhood Cancer in the St Jude Lifetime Cohort 2023 ·Journal of Clinical Oncology ·Stephanie B. Dixon, Fang Wang, Lu Lu, Carmen L. Wilson, Daniel M. Green, Thomas E. Merchant, Deo Kumar Srivastava, Angela Delaney, Rebecca M. Howell, John L. Jefferies, Leslie L. Robison, Kirsten K. Ness, Melissa M. Hudson, Wassim Chemaitilly, Gregory T. Armstrong	11
8	Sleep-related challenges and family functioning in children and adolescents previously treated for craniopharyngioma 2023 ·Journal of Psychosocial Oncology ·(unknown), (unknown), Marcia A. Winter, Thomas E. Merchant, Valerie McLaughlin Crabtree	2
9	Monitoring of Interfractional Proton Range Verification and Dosimetric Impact Based on Daily CBCT for Pediatric Patients with Pelvic Tumors 2023 ·Cancers ·(unknown), Jinsoo Uh, (unknown), Chia‐Ho Hua, Thomas E. Merchant, Matthew J. Krasin	2
10	Monte Carlo framework for commissioning a synchrotron-based discrete spot scanning proton beam system and treatment plan verification 2021 ·Biomedical Physics & Engineering Express ·V Moskvin, Austin M. Faught, (unknown), (unknown), Chia‐Ho Hua, Thomas E. Merchant	3
11	Creation of a successful multidisciplinary course in pediatric neuro‐oncology with a systematic approach to curriculum development 2020 ·Cancer ·Daniel C. Moreira, Amar Gajjar, Zoltán Patay, Frederick A. Boop, Jason Chiang, Thomas E. Merchant, Teresa Santiago, (unknown), (unknown), (unknown), (unknown), Miguela A. Caniza, Carlos Rodríguez‐Galindo, Ibrahim Qaddoumi	8
12	Establishing a Preclinical Multidisciplinary Board for Brain Tumors 2018 ·Clinical Cancer Research ·Birgit Nimmervoll, Nidal Boulos, (unknown), Jason Dapper, Michael DeCuypere, Anang A. Shelat, (unknown), (unknown), Amar Gajjar, Yogesh T. Patel, Burgess B. Freeman, Arzu Onar‐Thomas, Clinton F. Stewart, Martine F. Roussel, (unknown), Thomas E. Merchant, Christopher Calabrese, Karen Wright, Richard J. Gilbertson	9
13	Hyperbaric Oxygen Therapy for Radiation-Related CNS Necrosis in Children with Brain Tumors: A Single Institution Experience 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Charu Singh, Derek S. Tsang, Raja B. Khan, Thomas E. Merchant	3
14	A Phase II Trial of Conformal Radiation Therapy for Pediatric Patients With Localized Ependymoma, Chemotherapy Prior to Second Surgery for Incompletely Resected Ependymoma and Observation for Completely Resected, Differentiated, Supratentorial Ependymoma 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Thomas E. Merchant, Anne Bendel, Noah D. Sabin, P. C. Burger, (unknown), James M. Boyett	12
15	Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma 2013 ·Clinical Cancer Research ·Alberto Broniscer, Sharyn D. Baker, Cynthia Wetmore, Atmaram S. Pai Panandiker, Jie Huang, Andrew M. Davidoff, Arzu Onar‐Thomas, John C. Panetta, Thomas K. Chin, Thomas E. Merchant, Justin N. Baker, Sue C. Kaste, Amar Gajjar, Clinton F. Stewart	74
16	Induction Chemotherapy and Conformal Radiation Therapy for Very Young Children With Nonmetastatic Medulloblastoma: Children's Oncology Group Study P9934 2012 ·Journal of Clinical Oncology ·David M. Ashley, Thomas E. Merchant, Douglas Strother, Tianni Zhou, Patricia K. Duffner, Peter C. Burger, Douglas C. Miller, (unknown), Melanie J. Bonner, Michael E. Msall, Allen Buxton, Russell Geyer, Larry E. Kun, Lee Coleman, Ian F. Pollack	67
17	Radiation therapy for pediatric craniopharyngioma 2010 ·Neurosurgical FOCUS ·Erin N. Kiehna, Thomas E. Merchant	91
18	Risk factors associated with incomplete brainstem recovery following post-operative conformal radiation therapy for infratentorial ependymoma 2004 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Raja B. Khan, X. Xiong, Thomas E. Merchant	1
19	Current management of childhood ependymoma. 2002 ·PubMed ·Thomas E. Merchant	53
20	Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. 1992 ·PubMed ·Jason A. Koutcher, Alan Alfieri, M. Devitt, Juong G. Rhee, Alice B. Kornblith, Umar Mahmood, Thomas E. Merchant, David Cowburn	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact